ROCK of Africa Foundation is a humanitarian effort dedicated to fighting famine and disease in the Third World by providing food, medicine, tools and education.

ROCK of Africa Foundation is providing food, clothing, medicine and medical supplies to poverty stricken regions of Africa.  The foundation also promotes research and development of solutions to medical problems facing poor in underdeveloped countries in Africa and throughout the world. 

Medicine for Africa Research

Dr. Carl P. Schaffner

Under the direction of Carl P. Schaffner, Ph.D., professor emeritus at the Waksman Institute of Rutgers University, ROCK of Africa Foundation is assisting in development of new medicine to treat victims of HIV/AIDS in Africa. 

The vast majority of people infected with the HIV virus in sub-Saharan Africa receive no medicine at all to treat the virus.  The obvious reason is cost.  Teams of researchers in the US and Africa are donating their time to develop low cost medicines for treating disease in the Third World. 

ROCK of Africa Foundation has established collaborative research relationships with researchers in the United States, South Africa and Ghana, West Africa. 

AME -- Amphotericin B Methyl Ester

A patent free medication to treat HIV/AIDS victims in the Third World.  AME is a derivative of Amphotericin B, a highly effective medication for treatment of fungal disease.

Benefits of AME:

bullet

Low cost medication treatment for HIV/AIDS patients in the Third World
Medication free of patents, can legally be manufactured by any company.  Competitive manufacture is the key to lower cost.

bullet

Dual efficacy
In addition to fighting the HIV virus, AME is highly effective in fighting fungal disease which claims the lives of many AIDS patients.

bullet

Outpatient treatment from Rural Clinics
Unlike parent compound,
Amphotericin B which requires hospitalization to administer, AME could be administered by rural clinics on an outpatient basis.

for further information view:

AME -- a medical miracle?
a 30-minute documentary video featuring:

 Kenneth R. Reuhl, Ph.D.
Professor of Neurotoxicology
School of Pharmacy
Rutgers University
Carl P. Schaffner, Ph.D.
Director, AME Research Group
Professor Emeritus
Waksman Institute of Microbiology

Eric O. Freed, Ph.D.
Chief, Virus Cell Interaction Section
HIV Drug Resistance Program
National Cancer Institute
National Institutes of Health
Samuel Afrane, Ph.D.
Senior Lecturer
Kwame Nkrumah University
of Science and Technology
Kumasi, Ghana, West Africa

The research team headed by Dr. Schaffner includes: Dr. Robert Parsons, Basking Ridge, NJ; (the late Dr. Paul Hoeprich, Wilmington, DE conducted much research in this project until his death); and others. Africa based team members include: Dr. George Bedu-Addo; Dr. Sampson Agodzo; Dr. T. C. Fleischer; and Dr. Yao Dwomo-Fokuo.

For further information regarding the AME research project contact:  Research@ROCKofAfrica.org

Home   /   About   /   Foundation   /   Mission
The Crisis   /   News   /   Mailing List   /   Contact

© 2008 ROCK of Africa. All Rights Reserved.